汤新景团队联合王倩博士发展基于miRNA的PROTAC策略靶向降解Lin28蛋白并用于乳腺癌的联合治疗
北京大学药学院天然药物及仿生药物全国重点实验室
Prof. Xinjing Tang and Dr. Qian Wang developed a miRNA-based PROTACs strategy to target the degradation of Lin28 protein for the combined breast cancer therapy
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
中国药学(英文版)
.
2024, (9): 875
-876
.
>
>